Want to see JP:4461 full AI Analyst Report?
4461 Stock Chart & Stats
¥8230.00
-¥60.00(-1.64%)
At close: 4:00 PM EST
¥8230.00
-¥60.00(-1.64%)
Day’s Range― - ―
52-Week Range¥4,400.00 - ¥13,540.00
Previous CloseN/A
Volume29.40K
Average Volume (3M)144.71K
Market Cap
¥111.11B
Enterprise Value¥90.07K
Total Cash (Recent Filing)¥24.03B
Total Debt (Recent Filing)¥29.14B
Price to Earnings (P/E)17.5
Beta1.65
Next Earnings
Jul 29, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield1.43%
Share Statistics
EPS (TTM)601.45
Shares Outstanding10,684,321
10 Day Avg. Volume174,660
30 Day Avg. Volume144,713
Financial Highlights & Ratios
PEG Ratio0.10
Price to Book (P/B)1.45
Price to Sales (P/S)0.91
P/FCF Ratio11.91
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)612.6
Revenue Forecast (FY)¥87.00B
Bulls Say, Bears Say
Bulls Say
Revenue And Margin ReboundRevenue, margin and ROE recovery in 2026 signals renewed pricing power, better mix and operating leverage. Sustained improvement in core profitability strengthens cash generation capacity and funds reinvestment, reducing structural downside over the medium term.
Improved Leverage ProfileLower debt-to-equity and equity expansion materially improve financial flexibility and lower interest burden. A healthier balance sheet enhances the firm's ability to fund capex, absorb shocks and pursue strategic opportunities without immediate external financing.
Stronger Free Cash FlowConsistent positive free cash flow and high FCF-to-income ratios indicate better earnings quality and internal funding capability. Reliable FCF supports debt reduction, targeted reinvestment or shareholder returns, improving long-term capital allocation flexibility.
Bears Say
Earnings CyclicalityPronounced earnings volatility across recent years shows the business is sensitive to demand and cost swings. Such cyclicality complicates multi-period planning, raises required return thresholds and increases the chance of margin compression in weaker cycles.
Inconsistent Cash ConversionModest operating cash flow relative to revenue and a prior year of negative FCF reflect working-capital and investment sensitivity. Lumpy cash conversion can constrain reinvestment or debt servicing during downturns, increasing operational and financing risk.
Material Outstanding DebtDespite recent improvement, ~¥29B of debt is material and past behaviour shows leverage can rise in weaker periods. This exposure increases refinancing and interest-rate vulnerability, limiting strategic flexibility if earnings re-soften.
DKS Co., Ltd. News
4461 FAQ
What was DKS Co., Ltd.’s price range in the past 12 months?
DKS Co., Ltd. lowest stock price was ¥4400.00 and its highest was ¥13540.00 in the past 12 months.
What is DKS Co., Ltd.’s market cap?
DKS Co., Ltd.’s market cap is ¥111.11B.
When is DKS Co., Ltd.’s upcoming earnings report date?
DKS Co., Ltd.’s upcoming earnings report date is Jul 29, 2026 which is in 2 days.
How were DKS Co., Ltd.’s earnings last quarter?
DKS Co., Ltd. released its earnings results on May 13, 2026. The company reported ¥184.29 earnings per share for the quarter, missing the consensus estimate of N/A by N/A.
Is DKS Co., Ltd. overvalued?
According to Wall Street analysts DKS Co., Ltd.’s price is currently Overvalued.
Does DKS Co., Ltd. pay dividends?
DKS Co., Ltd. pays a Semiannually dividend of ¥75 which represents an annual dividend yield of 1.43%. See more information on DKS Co., Ltd. dividends here
What is DKS Co., Ltd.’s EPS estimate?
DKS Co., Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does DKS Co., Ltd. have?
DKS Co., Ltd. has 10,684,321 shares outstanding.
What happened to DKS Co., Ltd.’s price movement after its last earnings report?
DKS Co., Ltd. reported an EPS of ¥184.29 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -0.714%.
Which hedge fund is a major shareholder of DKS Co., Ltd.?
Currently, no hedge funds are holding shares in JP:4461
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
DKS Co., Ltd.
Headquartered in Kyoto, Japan, DKS Co. Ltd. is a global producer and purveyor of a diverse range of industrial chemicals and surfactants, serving numerous industries worldwide. The company’s operations are organized into six distinct segments: Surfactants, Amenity Materials, Polyurethane Materials, Functional Materials, Electronic Device Materials, and Life Sciences. Within its Surfactants division, DKS develops various types such as nonionic, anionic, cationic, polymerizable, and amphoteric compounds, in addition to specialized surfactant blends. The Amenity Materials segment features products like sucrose fatty acid esters, sodium carboxymethyl celluloses, cellulose nanofibers and other polymers, polyvinyl pyrrolidone, polyacrylamide and polyacrylate, and industrial deodorizers. Its Polyurethane Materials offerings include polyether polyols, urethane prepolymers, and comprehensive urethane systems. For Functional Materials, DKS manufactures radiation-curable monomers and oligomers, waterborne polyurethanes, flame retardants, and amide-based lubricants. The Electronic Device Materials group supplies ionic liquids, ion-conductive polymers, ceramic/metal injection molding components, conductive pastes for electronic applications, injection molding pellets, and advanced inorganic materials. Furthermore, the Life Sciences segment crafts health and dietary supplements, notably an I. Japonica-Bombyx Fungus product and Sudachin, a distinct citrus peel extract powder. Founded in 1909, the firm was formerly known as Dai-ichi Kogyo Seiyaku Co., Ltd. before rebranding to DKS Co. Ltd. in 2013.
Technical Analysis
T Hasegawa Co
―
Sanyo Chemical Industries
―
Tri Chemical Laboratories Inc.
―
Takasago International Corporation
―
MEC Company Ltd.
―